SINT Nasdaq Surgical & Medical Instruments & Apparatus Financials FY2016βFY2025
Sintx Technologies, Inc. had $1.0M of revenue in fiscal 2025, down 64.7% on the year before. Over five years, revenue changed +11.4% a year on average.
Last close Β· Oct 23, 2026
$1.58
3.7%Hi! I read Sintx Technologies, Inc.βs latest annual report (fiscal 2025). Here is what stands out:
Good So-so Weak
Are sales growing?
β64.7%
No. Sales fell 64.7% last year.
Does it make a profit?
β1,018.1%
No. It lost money last year.
Does profit turn into cash?
β860.1%
No. It spent more cash than it brought in.
How healthy are the accounts?
3 / 9
Weak. It passes 3 of 9 health tests.
How is the share priced?
β
No P/E: it made no profit over the last four quarters.
Rules of thumb on reported numbers. A starting point, not a recommendation.
Is it selling more, and how much does it keep?
In plain words: Every quarter, companies publish how much they sold and earned. These are the days Sintx Technologies, Inc. did it, and the next one. Share prices often move a lot on those days.
Next results
November 5, 2026
Thursday Β· in 10 days
| Date | Results for | Time | Source |
|---|---|---|---|
| Oct 1, 2026 | Period ended Sep 30, 2026 | Before the market opens | 8-K β |
| Aug 11, 2026 | Q2 '26 | After the market closes | 8-K β |
| May 15, 2026 | Q1 '26 | After the market closes | 10-Q β |
| Mar 20, 2026 | Q4 '25 | After the market closes | 10-K β |
| Nov 12, 2025 | Q3 '25 | After the market closes | 10-Q β |
| Aug 14, 2025 | Q2 '25 | After the market closes | 10-Q β |
| May 15, 2025 | Q1 '25 | Before the market opens | 8-K β |
| Mar 19, 2025 | Q4 '24 | Before the market opens | 10-K β |
From SEC filings: the results press release (8-K) or, without one, the quarterly or annual report.
KIRA Β· Sintx Technologies, Inc. had $1.0M of revenue in fiscal 2025, down 64.7% on the year before. Over five years, revenue changed +11.4% a year on average. Its operating margin was β1,053.1%, down 566.6Β pts: of every 100 in sales, about β1,053 is left after running the business.
In plain words: Revenue is all the money customers paid. The margins show how many cents of each dollar of sales are left over at each step: after making the product (gross), after running the business (operating) and after everything, tax included (net).
Revenue
Revenue
Margins, % of revenue
Margins, % of revenue
KIRA Β· Sintx Technologies, Inc. lost $10.4M in fiscal 2025.
Loss periods are shown in red.
In plain words: Net income is the profit left after every cost and tax. Earnings per share (EPS) splits that profit across every share, so it shows what one share earned.
Net income
Net income
Diluted EPS
Diluted EPS
How much cash comes in, and where does it go?
KIRA Β· Free cash flow was β$8.8M in fiscal 2025, β860.1% of revenue.
Cash from operations minus capital spending.
In plain words: Profit on paper is not the same as cash in the bank. Free cash flow is the cash left after paying to run and maintain the business: the money it can hand back to shareholders, save or invest.
Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations vs capital spending
KIRA Β· Sintx Technologies, Inc. returned $0.1M to shareholders in fiscal 2025. The diluted share count rose 272.4%.
In plain words: Companies hand cash back in two ways: dividends (cash paid to shareholders) and buybacks (buying back their own shares, so each remaining share owns a bigger slice).
Dividends and buybacks
Dividends and buybacks
Diluted shares outstanding (annual)
KIRA Β· No open-market insider trades in the last 12 months.
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. βPlanβ marks trades under a pre-arranged Rule 10b5-1 plan.
In plain words: Insiders are the people who run or own a big part of the company. Buying with their own money can signal confidence; selling often has personal reasons, like taxes or diversifying.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Can it carry its debts, and how well does it use its money?
KIRA Β· Sintx Technologies, Inc. has $4.1M more cash than debt.
Cash, debt and the ratios that show how comfortably Sintx Technologies, Inc. can carry it.
In plain words: What the company owns and what it owes. More cash than debt is a cushion for bad times; a lot of debt leaves less room when business slows down.
Cash vs debt (incl. leases)
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $14.3M | $6.2M | $3.3M | $3.6M | $4.1M |
| Debt incl. finance leases | $1.0M | $0.5M | $0.0M | $0.0M | $0.0M |
| Debt / equity | 0.1x | 0.1x | 0.0x | 0.0x | 0.0x |
| Current ratio | 5.5x | 0.9x | 1.9x | 2.3x | 1.5x |
| Quick ratio | 5.3x | 0.8x | 1.6x | 2.0x | 1.3x |
| Total assets | $21.8M | $15.8M | $15.4M | $9.4M | $9.5M |
| Total liabilities | $4.6M | $10.1M | $6.6M | $5.5M | $6.6M |
| Shareholders' equity | $17.2M | $5.7M | $8.8M | $3.9M | $2.9M |
| Net debt (β = net cash) | β$13.3M | β$5.7M | β$3.3M | β$3.6M | β$4.1M |
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
In plain words: How much profit the business makes on the money put into it. A higher percentage means each dollar invested works harder.
Return on capital, equity and assets (annual)
KIRA Β· Sintx Technologies, Inc. passes 3 of 9 financial health tests (Piotroski F-score).
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
In plain words: Nine yes/no tests of financial health, one point each. A green tick is a pass: 7 to 9 points is solid, 0 to 3 is weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 3 / 9 | 2 / 8 | 2 / 8 | 3 / 9 | 3 / 9 | 4 / 9 | 5 / 9 | 4 / 9 | 3 / 9 |
| Accruals ratio | β28.9% | β22.7% | 5.3% | 15.9% | 10.5% | 3.1% | β9.4% | 37.6% | β19.2% | β19.0% |
| Altman Z'' | β27.90 | β54.00 | β67.09 | β85.45 | β16.53 | β33.07 | β58.84 | β60.76 | β105.09 | β105.96 |
Every number, year by year.
Amounts in USD. Hover a ratioβs name for its definition.
In plain words: Every number we have, year by year. Download it as a spreadsheet if you want to dig deeper.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $15.2M | $11.2M | $0.1M | $0.7M | $0.6M | $0.6M | $1.6M | $2.6M | $2.9M | $1.0M |
| Gross profit | $11.4M | $4.9M | $0.0M | $0.1M | $0.1M | $0.2M | $1.3M | $1.8M | $2.1M | $0.5M |
| Research and development | $6.3M | $3.5M | $3.0M | $3.4M | $4.8M | $5.9M | $6.5M | $8.7M | $5.2M | $4.6M |
| Operating income | β$11.5M | β$7.5M | β$13.1M | β$6.6M | β$8.5M | β$10.6M | β$11.3M | β$13.4M | β$14.0M | β$10.7M |
| Pretax income | β$14.8M | β$5.8M | β$9.7M | β$4.8M | β$7.0M | β$9.3M | β$12.0M | β$8.3M | β$11.0M | β$10.4M |
| Net income | β$14.8M | β$9.3M | β$8.7M | β$4.8M | β$7.0M | β$9.3M | β$12.0M | β$8.3M | β$11.0M | β$10.4M |
| Net income to common | β$21.0M | β$0.0M | β$22.6M | β$7.5M | β$16.6M | β$9.3M | β$16.5M | β$8.3M | β$11.0M | β$17.1M |
| Diluted EPS | β$13.63 | β$3.13 | β$76.73 | β$5.69 | β$1.08 | β$39.91 | β$60.81 | β$624.47 | β$15.19 | β$6.16 |
| Diluted shares | 0.00B | 0.00B | 0.00B | 0.00B | 0.02B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B |
| Cash flow | ||||||||||
| Cash from operations | β$7.2M | β$4.7M | β$9.3M | β$6.4M | β$9.1M | β$10.1M | β$10.3M | β$14.1M | β$8.6M | β$8.6M |
| Capital expenditure | $0.7M | $0.0M | $0.0M | $0.1M | $0.4M | $3.7M | $1.4M | $0.5M | $0.7M | $0.2M |
| Free cash flow | β$7.8M | β$4.7M | β$9.4M | β$6.6M | β$9.5M | β$13.9M | β$11.7M | β$14.6M | β$9.3M | β$8.8M |
| Depreciation and amortization | $1.4M | $0.1M | $0.1M | $0.1M | $0.1M | $0.2M | $0.3M | $0.9M | $0.8M | $0.3M |
| Stock-based compensation | $0.3M | $0.2M | $0.0M | $0.0M | $0.0M | $0.3M | $0.4M | $0.3M | $0.1M | $1.4M |
| Share buybacks | β | β | β | β | β | β | β | β | β | $0.1M |
| Dividends and buybacks | β | β | β | β | β | β | β | β | β | $0.1M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $6.9M | $0.5M | $5.4M | $1.8M | $25.4M | $14.3M | $6.2M | $3.3M | $3.6M | $4.1M |
| Total debt | $7.0M | $3.0M | β | $0.0M | $0.4M | $1.0M | $0.5M | $0.0M | $0.0M | $0.0M |
| Current assets | $16.0M | $3.7M | $7.0M | $4.1M | $27.6M | $15.0M | $7.2M | $5.5M | $4.5M | $5.7M |
| Current liabilities | $14.0M | $8.3M | $2.4M | $2.1M | $2.9M | $2.7M | $8.1M | $2.9M | $2.0M | $3.7M |
| Inventory | $7.2M | $0.7M | $0.7M | $0.6M | $0.5M | $0.6M | $0.7M | $0.9M | $0.5M | $0.8M |
| Property and equipment, net | $0.9M | $0.2M | $0.1M | $0.2M | $0.5M | $4.0M | $5.7M | $4.8M | $0.9M | $0.5M |
| Goodwill | $6.2M | $6.2M | β | β | β | β | β | β | β | $0.3M |
| Intangible assets | $3.2M | $2.7M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.1M |
| Total assets | $26.3M | $14.6M | $11.5M | $9.1M | $30.4M | $21.8M | $15.8M | $15.4M | $9.4M | $9.5M |
| Total liabilities | $15.0M | $9.2M | $3.1M | $3.9M | $4.6M | $4.6M | $10.1M | $6.6M | $5.5M | $6.6M |
| Shareholders' equity | $11.2M | $5.4M | $8.4M | $5.2M | $25.8M | $17.2M | $5.7M | $8.8M | $3.9M | $2.9M |
| Margins | ||||||||||
| Gross margin | 75.2% | 43.4% | 41.1% | 20.0% | 20.0% | 25.9% | 83.0% | 70.2% | 71.9% | 45.3% |
| Operating margin | β75.8% | β66.7% | β13,806.3% | β957.0% | β1,431.6% | β1,752.5% | β726.1% | β508.5% | β486.6% | β1,053.1% |
| EBITDA margin | β66.3% | β65.7% | β13,695.8% | β942.2% | β1,418.5% | β1,721.9% | β704.7% | β474.0% | β457.4% | β1,021.8% |
| Net margin | β97.0% | β83.1% | β9,107.4% | β696.2% | β1,183.3% | β1,536.1% | β771.2% | β314.4% | β381.8% | β1,018.1% |
| FCF margin | β51.5% | β41.7% | β9,851.6% | β955.3% | β1,594.6% | β2,288.9% | β747.5% | β557.5% | β323.2% | β860.1% |
| Returns | ||||||||||
| Return on capital | β80.4% | β75.2% | β | β151.5% | β791.3% | β212.9% | β | β192.6% | β3,383.3% | β |
| Return on capital employed | β94.0% | β117.5% | β143.6% | β93.1% | β30.8% | β55.6% | β147.3% | β107.2% | β189.0% | β185.7% |
| Return on equity | β131.4% | β111.9% | β125.0% | β70.5% | β45.3% | β43.3% | β105.1% | β114.1% | β174.1% | β303.8% |
| Return on assets | β56.2% | β45.6% | β66.2% | β46.4% | β35.5% | β35.6% | β64.0% | β53.0% | β89.0% | β109.6% |
| Return on tangible equity | β1,116.2% | β | β270.0% | β145.3% | β64.4% | β54.2% | β290.4% | β94.7% | β284.3% | β687.4% |
| Growth | ||||||||||
| Revenue growth | β | β26.3% | β99.2% | 625.3% | β13.8% | 2.0% | 157.6% | 68.3% | 9.9% | β64.7% |
| Share count change | β | 93.0% | β87.1% | 305.3% | 1,021.2% | β98.6% | 26.6% | β93.1% | 3,316.5% | 272.4% |
| Financial health | ||||||||||
| Debt / equity | 0.6x | 0.5x | β | 0.0x | 0.0x | 0.1x | 0.1x | 0.0x | 0.0x | 0.0x |
| Current ratio | 1.1x | 0.4x | 2.9x | 2.0x | 9.6x | 5.5x | 0.9x | 1.9x | 2.3x | 1.5x |
| Quick ratio | 0.6x | 0.4x | 2.7x | 1.7x | 9.4x | 5.3x | 0.8x | 1.6x | 2.0x | 1.3x |
| Capital allocation | ||||||||||
| Capex / revenue | 4.4% | 0.1% | 11.6% | 21.3% | 60.6% | 617.8% | 90.0% | 20.2% | 23.9% | 18.2% |
| Stock comp / revenue | 1.8% | 2.0% | 44.2% | 0.3% | 7.6% | 51.0% | 23.6% | 11.1% | 2.8% | 136.5% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 3.0 | 2.0 | 2.0 | 3.0 | 3.0 | 4.0 | 5.0 | 4.0 | 3.0 |
| Altman Z'' | β27.9 | β54.0 | β67.1 | β85.5 | β16.5 | β33.1 | β58.8 | β60.8 | β105.1 | β106.0 |
| Accruals ratio | β28.9% | β22.7% | 5.3% | 15.9% | 10.5% | 3.1% | β9.4% | 37.6% | β19.2% | β19.0% |
Source: SEC EDGAR XBRL filings (CIK 0001269026). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.
